Article
Surgical Treatment of Benign Prostatic Hyperplasia (sponsored)
On January 10, 2015 Urology Times convened an expert panel to examine the criteria that constitute a gold standard for the treatment of male lower urinary tract symptoms (LUTS), or benign prostatic hyperplasia (BPH).
Surgical Treatment of Benign Prostatic Hyperplasia
What Defines a Gold Standard?
On January 10, 2015 Urology Times convened an expert panel to examine the criteria that constitute a gold standard for the treatment of male lower urinary tract symptoms (LUTS), or benign prostatic hyperplasia (BPH).
Related Videos
Andrew Armstrong, MD, shares 5-year data on enzalutamide plus ADT in mHSPC
Professor Dickon Hayne on bladder cancer data to watch for at ASCO 2025
Study findings highlight gender gaps in oncology authorship and citation
NMIBC Treatment Decisions in the Age of BCG Shortages
Current Standards of Care and Shifting Strategies in NMIBC
Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
BLUES trial: Silicone stents may improve patient care
Roshan Patel, MD, on the impact of restricted irrigation on PCNL outcomes
Targeted Therapy in mHSPC: Effects of Mutation Absence
Real-World Outcomes With Nadofaragene in BCG-Unresponsive NMIBC
Related Content
